Fair Market Value & KOL Tiering
Establishing FMV is not always an easy task. To help you and your life sciences organization establish FMV rates for engagements with healthcare professionals (HCPs), as well as non-HCPs, our fmvNOW™ tool is here to help. fmvNOW™ aids in protecting your company’s and product’s value through a variety of unique features with our novel application.
Global governing bodies have robust regulations and enforcement actions that address payments from manufacturers for consulting activities performed by healthcare professionals (HCPs) and non-HCPs (e.g., reimbursement specialists). The governments’ focus has been on the detection and prevention of bribes or corrupt payments to HCPs which could be seen as an inducement to prescribe product.
Specifically in the U.S., the Anti-Kickback Statue (AKS) makes it a crime to pay, offer, solicit or receive remuneration, directly or indirectly, to induce referrals or services of Medicare or Medicaid business. Further action under the Patient Protection and Affordable Care Act (PPACA) has expanded the AKS’ intent and specified that violations of the AKS may also trigger liability under the False Claims Act.
Globally, payments made outside of FMV can trigger a violation of the Foreign Corrupt Practices Act (U.S.), UK Bribery Act (U.K.), Clean Companies Act (Brazil) and Sapin II (France) among others. These violations have resulted in fines and damages in the hundreds of millions of dollars and, oftentimes, in disruptive Corporate Integrity Agreements (CIA) and Deferred Prosecution Agreements (DPA).
To make matters worse, governing bodies have started taking a look at publically available spend transparency data and conducting analytics to identify transfers of value that exceed FMV.
Baker Tilly works with clients to mitigate their risk and protect their value through the development of FMV rates to compensate for consulting services. Our methodology is based on three equally important elements:
In addition to providing HCP FMV rates, our team will document the methodology used.
Global regulatory focus is not just on payments to HCPs. FMV enforcement has expanded to include non-HCP related activities. Baker Tilly provides FMV analysis and methodologies to address these areas as well, including:
It is appropriate to compensate certain individuals at a higher FMV rate than others based on an objective assessment of individual expertise. Categories of expertise to be evaluated can include, but may not be limited to:
Depending on the level of expertise in each category, an individual can be assigned as a National/International Thought Leader, Regional Thought Leader or Local Thought Leader. This process is important to the overall methodology and in mitigating risk as it ensures that FMV rates are correctly applied across the thought leadership tiers. For example, if a regional thought leader is assigned the FMV rate for a national/international thought leader, this could result in an overpayment of more than 100% depending on the specific specialty and country.
Baker Tilly works with clients to operationalize their KOL tiering function by providing the following solutions:
Ensuring payments to HCPs and other non-HCP related services are being made at FMV is one of the more powerful controls a company can do to mitigate risk associated with the Anti-Kickback Statute and False Claims Act. It is also good business practice and allows your company to have more insight into how you are spending your money. Baker Tilly’s team of Value Architects™ can help your organization put this in place and protect your company's value.